Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 216 participants.
Also called NCT06262685
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 216 participants
- Registry
-
NCT06262685
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Unknown status
Technical summary
Registry record NCT06262685. Randomized; single masking; primary purpose treatment. Start 2024-03-04 (anticipated); primary completion 2025-02-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
- Acronym
- PREVESTATGx
- Condition
- Cardiovascular Diseases
- Condition
- Dyslipidemias
- Condition
- Statin Adverse Reaction
- Condition
- Pharmacogenic Myopathy
- Intervention (Other)
- Preemptive pharmacogenetic atorvastatin dose based on CPIC guidelines
- Intervention (Other)
- Preemptive pharmacogenetic simvastatin dose based on CPIC guidelines
- Intervention (Other)
- Preemptive pharmacogenetic pitavastatin dose based on CPIC guidelines
- Intervention (Other)
- Preemptive pharmacogenetic rosuvastatin dose based on CPIC guidelines
- Intervention (Other)
- Preemptive pharmacogenetic pravastatin dose based on CPIC guidelines
- Intervention (Other)
- Preemptive pharmacogenetic lovastatin dose based on CPIC guidelines
- Intervention (Other)
- Preemptive pharmacogenetic fluvastatin dose based on CPIC guidelines
- Intervention (Other)
- Standard of Care (SoC) dosing of atorvastatin
- Intervention (Other)
- Standard of Care (SoC) dosing of simvastatin
- Intervention (Other)
- Standard of Care (SoC) dosing of pitavastatin
- Intervention (Other)
- Standard of Care (SoC) dosing of rosuvastatin
- Intervention (Other)
- Standard of Care (SoC) dosing of prasavastatin
- Intervention (Other)
- Standard of Care (SoC) dosing of lovastatin
- Intervention (Other)
- Standard of Care (SoC) dosing of fluvastatin
- Lead sponsor
- Instituto de Investigación Hospital Universitario La Paz
- Collaborator
- Instituto de Salud Carlos III
Record details
- Record id
cardio:ct-nct06262685- Content hash
bfed0fb2a371a4f6929a9d056d93d77371c3970efb543e43982b9e80c6495c04